Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$68,387,083
-$4,780,633 QoQ
Shares Held
541,294
+3.1% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#178
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $252,849,441 across 15 Drug Manufacturers - General names. GILD ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
541,294 | $68,387,083 | |
| 2 | LLY |
ELI LILLY & Co
|
44,150 | $52,954,838 | |
| 3 | MRK |
Merck & Co., Inc.
|
264,831 | $34,030,783 | |
| 4 | ABBV |
AbbVie Inc.
|
129,445 | $32,573,539 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
365,001 | $21,031,357 | |
| 6 | AMGN |
Amgen Inc
|
40,262 | $14,579,675 | |
| 7 | JNJ |
Johnson & Johnson
|
34,792 | $8,836,124 | |
| 8 | NVS |
Novartis AG
|
31,082 | $4,871,171 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,387,083 | 541,294 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $73,167,716 | 524,989 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $67,742,906 | 551,922 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $58,630,533 | 528,203 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $56,878,638 | 513,021 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $61,917,037 | 552,584 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $49,900,121 | 540,220 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $44,559,199 | 531,479 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $34,105,893 | 497,098 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $35,558,553 | 485,441 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $41,484,977 | 512,097 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $38,634,416 | 515,538 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $39,487,739 | 512,362 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $38,911,352 | 468,981 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,884,041 | 348,096 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $20,520,190 | 332,634 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $20,322,509 | 328,790 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $19,143,078 | 322,003 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $16,709,303 | 230,124 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $13,670,483 | 195,712 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $13,473,560 | 195,666 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $12,020,469 | 185,989 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $10,825,407 | 185,812 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $12,048,310 | 190,668 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $15,262,049 | 198,363 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,796,937 | 211,302 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||